These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3835424)

  • 21. Application of criminal antitrust sanctions to health care professionals.
    Berg RN
    J Med Assoc Ga; 1989 Feb; 78(2):102-4. PubMed ID: 2918255
    [No Abstract]   [Full Text] [Related]  

  • 22. A competitive analysis of most favored nations clauses in contracts between health care providers and insurers.
    Celnicker A
    Spec Law Dig Health Care (Mon); 1991 Dec; (154):7-36. PubMed ID: 10115476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitrust ruling could affect several health professions.
    Health Educ Rep; 1980 Jul; 2(13):4-6. PubMed ID: 10247256
    [No Abstract]   [Full Text] [Related]  

  • 24. When do hospital pharmacists violate antitrust laws?
    Decker R
    Hosp Purch Manage; 1980 Mar; 5(3):12-5. PubMed ID: 10245413
    [No Abstract]   [Full Text] [Related]  

  • 25. Law-medicine notes: Health planning, Blue Cross, and the federal antitrust laws.
    Curran WJ
    N Engl J Med; 1981 Nov; 305(20):1194-5. PubMed ID: 6169992
    [No Abstract]   [Full Text] [Related]  

  • 26. Antitrust in health care.
    Boland JM
    Colo Med; 1982 Mar; 79(3):116-8. PubMed ID: 6896026
    [No Abstract]   [Full Text] [Related]  

  • 27. [Constitutionality of section 116 b SGB V--legal requirements for ambulant medical services in hospitals].
    Wienke A; Janke K
    Laryngorhinootologie; 2009 Jun; 88(6):407-9. PubMed ID: 19504410
    [No Abstract]   [Full Text] [Related]  

  • 28. The health care industry and antitrust: a continuing exploration.
    Weissburg C; Waxman JM
    Rev Fed Am Hosp; 1983; 16(4):57, 60. PubMed ID: 10260804
    [No Abstract]   [Full Text] [Related]  

  • 29. Exclusive contracts under antitrust attack.
    Reed TJ; Allen HS
    Hosp Med Staff; 1982 Nov; 11(11):2-9. PubMed ID: 10257181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative delivery systems are focus of antitrust scrutiny.
    Scammon DL; Fuller DA; Sheffet MJ
    J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715
    [No Abstract]   [Full Text] [Related]  

  • 32. Ore. upstart takes on rival.
    Taylor M
    Mod Healthc; 2002 Feb; 32(6):18-9, 21. PubMed ID: 11892528
    [No Abstract]   [Full Text] [Related]  

  • 33. States can't shield peer review from antitrust--high court.
    Burda D
    Mod Healthc; 1988 May; 18(21):5. PubMed ID: 10324515
    [No Abstract]   [Full Text] [Related]  

  • 34. Antitrust and the new competition in health care: excerpts.
    Ginsburg DH
    Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459
    [No Abstract]   [Full Text] [Related]  

  • 35. An antitrust primer for physicians.
    Anders GT; Beck LC; Bak BB; Gallagher JW
    Pa Med; 1984 Jul; 87(7):46-8. PubMed ID: 6540856
    [No Abstract]   [Full Text] [Related]  

  • 36. Physicians under siege: the Federal Trade Commission versus the physicians of St. Francis Hospital.
    Rosen BF
    Med Staff Couns; 1988; 2(4):73-6. PubMed ID: 10290186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Courts and Congress shield peer review process from antitrust liability.
    Halper HR
    Bus Health; 1987 Jan; 4(3):59. PubMed ID: 10280004
    [No Abstract]   [Full Text] [Related]  

  • 38. Peer review of fees by physician groups: antitrust issues.
    Scott M
    Health Law Vigil; 1986 Jul; 9(14):5-8. PubMed ID: 10277308
    [No Abstract]   [Full Text] [Related]  

  • 39. New face at the bargaining table.
    McCann RW; Tomaselli LA
    Hospitals; 1983 Oct; 57(20):75-9. PubMed ID: 6352455
    [No Abstract]   [Full Text] [Related]  

  • 40. Vertical restraints and powerful health insurers: exclusionary conduct masquerading as managed care?
    Miller FH
    Law Contemp Probl; 1988; 51(2):195-236. PubMed ID: 10295963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.